CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported a loss of $17 million in its second quarter.

The Canton, Massachusetts-based company said it had a loss of 13 cents per share.

The regenerative medicine company posted revenue of $130.2 million in the period.

Organogenesis expects full-year revenue in the range of $445 million to $470 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO